Quest Diagnostics (0KSX) Ratios
Quest Diagnostics Ratios
GB:0KSX's free cash flow for Q3 2026 was $574.00M. For the 2026 fiscal year, GB:0KSX's free cash flow was decreased by $-166.00M and operating cash flow was $740.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.04 | 1.10 | 1.31 | 1.22 | 1.56 |
| Quick Ratio | 0.96 | 1.02 | 1.20 | 1.10 | 1.44 |
| Cash Ratio | 0.18 | 0.25 | 0.38 | 0.20 | 0.50 |
| Solvency Ratio | 0.17 | 0.15 | 0.17 | 0.20 | 0.34 |
| Operating Cash Flow Ratio | 0.83 | 0.62 | 0.70 | 1.11 | 1.27 |
| Short-Term Operating Cash Flow Coverage | 2.78 | 1.42 | 2.17 | 6.96 | 8.30 |
| Net Current Asset Value | $ -6.56B | $ -6.87B | $ -5.23B | $ -4.93B | $ -4.31B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.43 | 0.44 | 0.39 | 0.37 | 0.35 |
| Debt-to-Equity Ratio | 0.96 | 1.05 | 0.87 | 0.80 | 0.74 |
| Debt-to-Capital Ratio | 0.49 | 0.51 | 0.47 | 0.44 | 0.43 |
| Long-Term Debt-to-Capital Ratio | 0.44 | 0.45 | 0.41 | 0.40 | 0.38 |
| Financial Leverage Ratio | 2.26 | 2.38 | 2.22 | 2.18 | 2.11 |
| Debt Service Coverage Ratio | 1.97 | 1.39 | 1.98 | 3.94 | 6.09 |
| Interest Coverage Ratio | 5.79 | 5.96 | 7.74 | 9.65 | 15.66 |
| Debt to Market Cap | 0.33 | 0.39 | 0.32 | 0.23 | 0.20 |
| Interest Debt Per Share | 64.83 | 65.88 | 50.54 | 41.91 | 39.40 |
| Net Debt to EBITDA | 2.96 | 3.45 | 2.78 | 2.42 | 1.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 31.93% | 32.86% | 33.17% | 34.74% | 39.02% |
| EBIT Margin | 14.72% | 14.19% | 13.98% | 13.99% | 25.50% |
| EBITDA Margin | 19.88% | 19.19% | 18.72% | 18.42% | 29.28% |
| Operating Profit Margin | 14.53% | 13.63% | 13.64% | 14.45% | 22.07% |
| Pretax Profit Margin | 12.32% | 12.09% | 12.49% | 12.94% | 24.81% |
| Net Profit Margin | 8.99% | 8.82% | 9.23% | 9.57% | 18.49% |
| Continuous Operations Profit Margin | 9.48% | 9.33% | 9.81% | 10.27% | 19.28% |
| Net Income Per EBT | 72.94% | 72.95% | 73.88% | 73.96% | 74.52% |
| EBT Per EBIT | 84.84% | 88.71% | 91.60% | 89.57% | 112.43% |
| Return on Assets (ROA) | 6.11% | 5.39% | 6.09% | 7.37% | 14.66% |
| Return on Equity (ROE) | 13.84% | 12.85% | 13.54% | 16.05% | 30.96% |
| Return on Capital Employed (ROCE) | 11.49% | 9.63% | 10.34% | 12.65% | 20.08% |
| Return on Invested Capital (ROIC) | 8.43% | 6.96% | 7.75% | 9.83% | 15.26% |
| Return on Tangible Assets | 17.58% | 15.74% | 16.67% | 20.91% | 37.30% |
| Earnings Yield | 5.15% | 5.20% | 5.53% | 5.21% | 9.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.84 | 7.57 | 7.65 | 8.27 | 7.50 |
| Payables Turnover | 4.70 | 23.09 | 16.40 | 19.91 | 18.43 |
| Inventory Turnover | 39.75 | 35.26 | 32.63 | 33.59 | 31.63 |
| Fixed Asset Turnover | 3.86 | 3.57 | 3.83 | 4.20 | 4.68 |
| Asset Turnover | 0.68 | 0.61 | 0.66 | 0.77 | 0.79 |
| Working Capital Turnover Ratio | 68.33 | 25.31 | 20.47 | 14.81 | 9.50 |
| Cash Conversion Cycle | -21.99 | 42.76 | 36.67 | 36.66 | 40.39 |
| Days of Sales Outstanding | 46.57 | 48.21 | 47.74 | 44.13 | 48.65 |
| Days of Inventory Outstanding | 9.18 | 10.35 | 11.19 | 10.87 | 11.54 |
| Days of Payables Outstanding | 77.74 | 15.80 | 22.26 | 18.33 | 19.81 |
| Operating Cycle | 55.76 | 58.57 | 58.92 | 55.00 | 60.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 16.99 | 12.02 | 11.36 | 14.81 | 17.86 |
| Free Cash Flow Per Share | 12.24 | 8.19 | 7.71 | 11.33 | 14.64 |
| Dividend Paid and CapEx Coverage Ratio | 2.14 | 1.76 | 1.76 | 2.42 | 3.14 |
| Capital Expenditure Coverage Ratio | 3.58 | 3.14 | 3.12 | 4.25 | 5.54 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.19 | 0.23 | 0.36 | 0.47 |
| Operating Cash Flow to Sales Ratio | 0.17 | 0.14 | 0.14 | 0.17 | 0.21 |
| Free Cash Flow Yield | 7.06% | 5.43% | 5.59% | 7.24% | 8.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.56 | 19.23 | 18.08 | 19.18 | 10.84 |
| Price-to-Sales (P/S) Ratio | 1.75 | 1.70 | 1.67 | 1.84 | 2.00 |
| Price-to-Book (P/B) Ratio | 2.69 | 2.47 | 2.45 | 3.08 | 3.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 14.17 | 18.42 | 17.87 | 13.81 | 11.82 |
| Price-to-Operating Cash Flow Ratio | 10.21 | 12.55 | 12.14 | 10.56 | 9.68 |
| Price-to-Earnings Growth (PEG) Ratio | 1.43 | 6.95 | -2.77 | -0.39 | 0.22 |
| Enterprise Value Multiple | 11.74 | 12.29 | 11.69 | 12.39 | 8.08 |
| Enterprise Value | 25.76B | 23.28B | 20.25B | 22.55B | 25.53B |
| EV to EBITDA | 11.74 | 12.29 | 11.69 | 12.39 | 8.08 |
| EV to Sales | 2.33 | 2.36 | 2.19 | 2.28 | 2.37 |
| EV to Free Cash Flow | 18.96 | 25.61 | 23.44 | 17.16 | 13.95 |
| EV to Operating Cash Flow | 13.66 | 17.45 | 15.92 | 13.12 | 11.43 |
| Tangible Book Value Per Share | -29.68 | -33.54 | -22.15 | -19.87 | -13.60 |
| Shareholders’ Equity Per Share | 64.59 | 61.06 | 56.31 | 50.80 | 51.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.23 | 0.21 | 0.21 | 0.22 |
| Revenue Per Share | 99.41 | 88.94 | 82.61 | 85.20 | 86.30 |
| Net Income Per Share | 8.94 | 7.85 | 7.63 | 8.16 | 15.96 |
| Tax Burden | 0.73 | 0.73 | 0.74 | 0.74 | 0.75 |
| Interest Burden | 0.84 | 0.85 | 0.89 | 0.92 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.18 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.80 | 1.45 | 1.40 | 1.69 | 1.07 |
Currency in USD
